Verona Pharma plc (VRNA) Tops Q1 EPS by 8c

Verona Pharma plc (NASDAQ: VRNA) reported Q1 EPS of ($0.03), $0.08 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
• B. Riley previews Semi Cap Equipment sector ahead of Semicon West